“….1028934 Vachiramon et al, 2013Zhou et al, 2015;Alam et al, 2016;Firmeza et al, 2017;Rossetti et al, 2017;Wren et al, 2019;Al-Jubouri et al, 2021;Mishra et al, 2022) were included in the present analysis involving 1,320 patients with cancer (Table 1). Among these trials, the majority of them (7/15) were conducted in America (Kwekkeboom, 2003;Danhauer et al, 2010;Vachiramon et al, 2013;Alam et al, 2016;Rossetti et al, 2017;Wren et al, 2019;Mishra et al, 2022), followed by four in China (Lin et al, 2011;Li et al, 2012;Chen et al, 2013;Zhou et al, 2015), one in Italy (Bulfone et al, 2009), one in Iraq (Al-Jubouri et al, 2021), one in Australia (O'Callaghan et al, 2012), and one in Brazil (Firmeza et al, 2017). Four studies included patients who had been diagnosed with breast cancer (Bulfone et al, 2009;Li et al, 2012;Zhou et al, 2015;Wren et al, 2019), two studies included patients with skin cancer (Vachiramon et al, 2013;Alam et al, 2016), one study included patients with prostate cancer (Mishra et al, 2022), one study included hematological malignancies (Danhauer et al, 2010), and one study included patients with head and neck cancer (Firmeza et al, 2017).…”